Event

EP PerMed JTC2027 Information Session

4.12.2026 at 10.00-11.00

National Eligibility Requirements and Application Process

Join the teams event to learn what the European Partnership for Personalised Medicine Joint Transnational Call 2027, “Cell and Gene Therapy for Personalised Medicine” (CGT4PM2027) means for Finnish applicants. Business Finland’s information session will cover national funding requirements, the stages of the application process and key practical considerations.

Starts 04.12.2026

Registration

Register now

Language of the event: Finnish and English

Are you planning to participate in the EP PerMed JTC2027 Joint Transnational Call? 

This information session, organised by Business Finland, will examine the call from the perspective of the national funding organisation. The session will explain the conditions under which Business Finland may fund Finnish applicants, and give an overview of how the international joint call and the national funding process proceed, and what applicants should take into account during preparation.

The information session is intended for organisations that are considering applying or are preparing an application with Finnish and international partners. The focus will be on the national eligibility and funding requirements and the practical application process. .

For more detailed information on the call topic and the international requirements, please study Pre-announcement - EP PerMed Joint Transnational Call (JTC) 2027 - European Partnership for Personalised Medicine and attend the information session organised by EP PerMed on 3 December 2026. Business Finland’s session will cover the international requirements and scientific themes of the JTC2027 call only at a general level.